Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial Hypertension
Christoph Sinning(Johannes Gutenberg University Mainz), Ekkehard Grünig(Heidelberg University), Stefan Blankenberg(Universität Hamburg), Nicola Benjamin(Heidelberg University), Benedikt Schrage(Inserm), Dirk Westermann(University Medical Center Freiburg), Benjamin Waschki(University of Lübeck), Francisco Ojeda(Universidad Complutense de Madrid), Nicole Rübsamen(University of Münster), Wilko H. Kleemann(Universität Hamburg), Lars Harbaum(Universität Hamburg), Maria Kögler(Heidelberg University), Benjamin Egenlauf(Heidelberg University), Christine Fischer(Heidelberg University), Ulrich Schäfer(Universität Hamburg), Hans F. Klose(Universität Hamburg), Christina Magnussen(Universität Hamburg), Elvin Zengin(Universität Hamburg), Kaaja M. Baaske(Universität Hamburg)
Cited by 6
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease
|Circulation|2003|755
Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility
|PLoS ONE|2010|600
An official European Respiratory Society statement on physical activity in COPD
|European Respiratory Journal|2014|519